Companies /Healthcare

Rallybio Corp

NASDAQ: RLYB Biotechnology

$16.81

▲ $0.05 (+0.30%) today

Markets closed · 8:50pm ET

Today · % change

Fundamentals

Market Cap

$89.0M

P/E Ratio

2.1

Profit Margin

7,051.0%

Revenue (TTM)

$646,000

EPS (TTM)

$7.88

52-Week Range

$4 – $18

Street Target

$8.00

About Rallybio

None

RLYB Coverage

10:05am ET

Investing

Stock Splits Matter: Notable Splits in 2025 and What’s Happening in 2026

Here is a look at why companies split their stocks and why it matters, with context on the major splits of 2025 and 2026 including Netflix, ServiceNow, Booking Holdings, and KLA Corporation.

AAPL AMZN CMG

Trey Thoelcke